detection and surveillance of iugr
TRANSCRIPT
![Page 1: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/1.jpg)
Fetal Growth Disorders:Detection and Surveillance of IUGR
Sheila F. Perillo, MD
![Page 2: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/2.jpg)
Objective
To discuss the diagnosis, classification and management of IUGR
![Page 3: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/3.jpg)
Intrauterine growth restriction (IUGR) refers to inability of a fetus to achieve full growth
potential while in utero.
birth weight below the 10th percentile for gestational age
Other definitions: weight at birth <2500 g EFW <10th percentile AC <10th percentile EFW <10th percentile with abnormal Doppler indices in the
umbilical artery or middle cerebral artery AC <10th percentile with abnormal umbilical artery or middle
cerebral artery Doppler studies
![Page 4: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/4.jpg)
Etiologies Genetic factors
40% of total birth weight- genetic factors 60% - fetal environmental contributions
women who were growth restricted or SGA at birth are at increased risk of having an IUGR fetus
maternal genotypic disorders can cause growth restriction, including phenylketonuria and dysmorphic syndromes such as dwarfism *
chromosomal anomalies associated with IUGR:▪ Approximately 50% of fetuses with Trisomy 13 or Trisomy 18 have fetal
growth restriction▪ confined placental mosaicism has been associated with growth restriction
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin Number 12. Intrauterine Growth Restriction. Washington, DC, 2000
![Page 5: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/5.jpg)
Etiologies Congenital anomalies
Fetuses with congenital anomalies, including cardiac malformations (as many as 50% to 80% of fetuses with septal defects), anencephaly, and umbilical artery anomalies, including abnormal cord insertions
25% of fetuses with a 2-vessel umbilical cord weigh less than 2500 g at birth *
Gastroschisis also is often associated with growth restriction and is present in up to 25% of cases **
*. Froehlich LA, Fujikura T. Significance of a single umbilical artery. Report from the collaborative study of cerebral palsy. Am J Obstet Gynecol. 1966;94(2):274-279.
**. Raynor BD, Richards D. Growth retardation in fetuses with gastroschisis. J Ultrasound Med. 1997;16(1):13-6.
![Page 6: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/6.jpg)
Etiologies Infection
Intrauterine infection underlies 5% to 10% of IUGR.*
Worldwide, malaria accounts for the majority of infection-related growth restriction.
Viral infectious etiologies include cytomegalovirus, rubella, toxoplasmosis, herpes zoster, human immunodeficiency virus, varicella, and syphilis.
Chorioamnionitis is strongly associated with symmetric growth restriction between 28 and 36 weeks’ gestation, and with asymmetric growth restriction after 36 weeks’ gestation.**
*. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin Number 12. Intrauterine Growth Restriction. Washington, DC, 2000.
**. Williams MC, et al. Histologic chorioamnionitis is associated with fetal growth restriction in term and preterm infants. Am J Obstet Gynecol. 2000;183(5):1094-1099.
![Page 7: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/7.jpg)
Etiologies Multiple gestations
25% risk of IUGR in twin pregnancies and a 60% risk for higher-order gestations*
Monochorionic pregnancies are at an additional risk of discordant fetal growth restriction because of twin-twin transfusion syndrome or unequal placental blood and nutrient sharing.
* Mauldin JG, Newman RB, Mauldin PD. Cost-effective delivery management of the vertex and nonvertex twin gestation. Am J Obstet Gynecol. 1998;179(4):864-869.
![Page 8: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/8.jpg)
EtiologiesMaternal nutrition
Severely decreased maternal caloric and protein intake during pregnancy
Glucose uptake from maternal circulation is the primary source for the fetus, and the maternal-fetal glucose concentration has been shown to increase in growth restriction.*
*. Hovdenak N, Haram K. Influence of mineral and vitamin supplements on pregnancy outcome. Eur J Obstet Gynecol Reprod Biol. 2012;164(2):127-132.
![Page 9: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/9.jpg)
Maternal Nutrition Decreases in serum concentrations of zinc and
folate have been associated with growth restriction.* The most important “nutrient” deficiency causing IUGR
is oxygen. ** Many maternal conditions, including
hemoglobinopathies, chronic pulmonary disease, and severe maternal kyphoscoliosis, increase risk of IUGR.
*. Marconi AM, et age and fetal growth on the maternal-feal. The impact of gestational tal glucose concentration difference. Obstet Gynecol. 1996;87(6):937-942.
** Lackman F et al. Fetal umbilical cord oxygen values and birth to placental weight ratio in relation to size at birth. Am J Obstet Gynecol. 2001;185(3):674-682.
![Page 10: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/10.jpg)
Environmental toxins Maternal cigarette smoking, excess alcohol
ingestion (ie, 2 or more drinks daily), and illicit drug use (specifically cocaine abuse)
Cigarette smoking symmetrically decreases birth weight by 135 to 300 g, but if stopped before the third trimester, the adverse effects are reduced.*
Phenytoin, warfarin, and trimethadione, has been associated with an increased IUGR risk depending on the timing, dosage, and known teratogenic effect.
*. Wen SW et al. Smoking, maternal age, fetal growth, and gestational age at delivery. Am J Obstet Gynecol. 1990;162(1):53-58.
![Page 11: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/11.jpg)
Placental factors Placental insufficiency is the major
placental abnormality seen in IUGR but there are many other placental disorders, including abruption, infarction, hemangioma, chrioangioma, and circumvallate shape
![Page 12: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/12.jpg)
Maternal vascular disease Diabetes, chronic hypertension,
pregnancy induced hypertension, advancing age, and morbid obesity
![Page 13: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/13.jpg)
Detection
Diagnosis by maternal physical examination alone has proven to be inaccurate in up to 50% of cases.
A single fundal height measurement at 32 to 34 weeks’ gestation has been reported to be approximately 65% to 85% sensitive and 96% specific for detecting the growth-restricted fetus.*
*American College of Obstetricians and Gynecologists. ACOG Practice Bulletin Number 12. Intrauterine Growth Restriction. Washington, DC, 2000.
![Page 14: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/14.jpg)
When IUGR is suspected by maternal fundal height, ultrasound for EFW assessment should be performed using fetal biometry: ▪ If the EFW is below the 10thpercentile, further sonographic
evaluation should be performed, including Doppler flow studies, amniotic fluid assessment, and evaluation for structural abnormalities.
During initial evaluation, it is important to note whether growth restriction is symmetric, asymmetric, or a mixed pattern.▪ Intrinsic insults that occur early in pregnancy are likely to result
in a symmetric growth restriction▪ Extrinsic insult occurring later in pregnancy will likely result in
asymmetric growth restriction
![Page 15: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/15.jpg)
Proposed alternative grouping is as follows: 1) Small for gestational age (SGA) ▪ small fetuses with no discernible pathology and
with normal umbilical artery and middle cerebral artery Doppler results
2) Growth-restriction ▪ small fetuses with recognizable pathology and
abnormal Doppler studies 3) Idiopathic growth restriction ▪ small fetuses with no discernable pathology and
abnormal Doppler studies
![Page 16: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/16.jpg)
Staging of IUGR has also been proposed: Stage 0 includes fetuses with an EFW or an AC
<10th percentile. Doppler of the umbilical artery and middle cerebral artery is normal.
Stage I includes fetuses whose EFW or AC is <10th percentile plus abnormal Doppler flow of the umbilical artery or middle cerebral artery.
·Stage II includes fetuses whose EFW or AC is <10th percentile plus absent or reversed Doppler flow of the umbilical artery.
Stage III includes fetuses whose EFW or AC is <10th percentile plus absent or reversed Doppler flow of the ductus venosus.
![Page 17: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/17.jpg)
Staging system and management
Stage 0 SGA fetuses Good prognosis Managed as outpatient with Doppler
assessment every 2 weeks. ·Stage I IUGR fetuses
Mild growth restriction Mothers without preeclampsia-
managed as outpatients Antenatal corticosteroids Twice-weekly antenatal testing
![Page 18: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/18.jpg)
Stage II IUGR fetuses managed as inpatients hospital admission: daily antenatal testing with
twice-daily NST and daily biophysical profile (BPP) antenatal corticosteroids Delivery is recommended at 34 weeks. Delivery should occur via cesarean delivery
Stage III IUGR fetuses managed the same as Stage II except for delivery
at 32 weeks’ gestation, regardless of gestational age at time of diagnosis
antenatal corticosteroids
![Page 19: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/19.jpg)
Rate of mortality in the staging system: Stage 0 or 1- no deaths occurred Stage III fetuses – mortality is high ▪ 50% if there was reversal of flow in the ductus
venosus▪ 85% mortality was observed when reversal of flow
in the ductus venosus was present in combination with one of the other parameters that characterize stage III)
stage II IUGR fetuses – mortality was intermediate between stages I and III
![Page 20: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/20.jpg)
IUGR fetuses are categorized as: very early IUGR (diagnosed at ≤29
weeks) early IUGR (diagnosed between >29
and <34 weeks) late IUGR fetuses (diagnosed following
34 weeks).
![Page 21: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/21.jpg)
Timing of delivery The loss of the “brain-sparing effect” was initially
considered a parameter to guide timing of delivery.*
Early Doppler changes occur in all the IUGR fetuses Late Doppler changes occur in idiopathic IUGR In idiopathic IUGR fetuses, the changes occur one after
the other and they are predictable.
In preeclamptic patients, however, the changes are unpredictable- delivery is done for maternal indication.**
▪ death in a case of lupus anticoagulant. Am J Obstet Gynecol. 1991;164(3):776-778.▪ **. Mari G, Hanif F, Kruger M, Sequence of cardiovascular changes in IUGR in
pregnancies with and without preeclampsia. Prenat Diagn. 2008;28(5):377-383.
![Page 22: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/22.jpg)
Timing of delivery for very premature growth-restricted fetuses In terms of survival rate, the growth-restricted fetus
delivered at >25 and <30 weeks is the most problematic.
Growth-restricted fetuses delivered at <25 weeks’ gestation do not survive
All growth-restricted fetuses survived when delivered at >30 weeks’ gestation
Very early IUGR fetuses in the presence of either a Category III NST or an abnormal BPP (4/8 confirmed at 2 hours apart in presence of Category II NST or in the presence of a BPP of 2/8 independently by the NST) DELIVER
![Page 23: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/23.jpg)
Doppler ultrasound as an indication for delivery
Stage I or higher IUGR involving abnormal Doppler studies should be monitored closely.
Antenatal testing is recommended and frequency ranges from twice weekly to multiple times daily, depending on level of severity.
If antenatal testing is Category III, then immediate delivery is warranted.
![Page 24: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/24.jpg)
Delivery mode for IUGR fetuses
Cesarean delivery for a growth-restricted fetus when there is absent or reversed flow of the umbilical artery because these fetuses rarely tolerate attempts at vaginal delivery
Fetus ≥34 weeks with an abnormal umbilical artery S/D ratio but a normal BPP is not likely to tolerate labor
![Page 25: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/25.jpg)
Contemporary Obgyn Detection and surveillance of IUGR by Giancarlo Mari MD, Danielle L. Tate MD
October 01, 2013
![Page 26: Detection and surveillance of iugr](https://reader033.vdocument.in/reader033/viewer/2022052313/58eeed641a28ab25388b467b/html5/thumbnails/26.jpg)
Thank you